Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

NCT03592121 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunction
Sexual Arousal Disorder
Sexual Dysfunction, Physiological
Breast Cancer
Nipple Disorder
Neuropathy
Cancer of Breast

Interventions

DRUG: AB-101
DRUG: Placebo

Sponsor

Applied Biology, Inc.